COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) reported Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 of $86.37 per share for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 · last filed 2024-07-17
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2023-12-31 | $86.37 20-F/A · filed 2024-07-17 | |
| 2022-12-31 | $165.08 20-F/A · filed 2024-07-17 | |
| 2021-12-31 | $14000.00 20-F/A · filed 2024-07-17 | $14756.25 6-K/A · filed 2022-08-04 |
| 2020-12-31 | $53.50 20-F/A · filed 2024-02-15 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2020-12-31 | 22.80 CAD/shares 20-F/A · filed 2024-02-15 |